Trial Profile
A retrospective study assessing the efficacy and safety of the long-term use of nimotuzumab in combination with intensity-modulated radiotherapy (IMRT) and chemotherapy in the treatment of advanced nasopharyngeal carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Sep 2018
Price :
$35
*
At a glance
- Drugs Nimotuzumab (Primary) ; Cisplatin; Docetaxel; Fluorouracil; Gemcitabine
- Indications Carcinoma; Nasopharyngeal cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Sep 2018 New trial record